Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Specialised Therapeutics Ltd, Clinician, Consumer",Nab-paclitaxel,Metastatic breast cancer,Nab-paclitaxel (Abraxane),Options for investment,Community and Hospital,Oncology Agents and Immunosuppressants
